Ansuman Satpathy
Gründer bei Immunai, Inc.
Profil
Ansu is a venture partner at Wing, where he focuses on investments at the interface of data, computation, and disease therapeutics.
He is excited to partner closely with early-stage founders, including academic spin-outs, using his firsthand scientific, clinical, and founder experience to build data-driven therapeutics companies.
Ansu is a physician-scientist by training and a Professor of Pathology and Immunology at Stanford University.
He is also an investigator in the Gladstone Institute of Genomic Immunology, the Parker Institute for Cancer Immunotherapy, and the Stanford Cancer Institute.
Ansu's academic research combines expertise in cancer biology, immunology, and high-throughput genomics and computation to discover principles of the immune dysfunction in disease and to translate these discoveries into novel clinical therapeutics.
He has previously co-founded several biotechnology companies, including Cartography Biosciences (a Wing portfolio company) and Immunai.
Ansu holds a BS in molecular biology and BA in philosophy from the University of Illinois, an MD and PhD in immunology from Washington University in St.Louis, and completed his clinical residency and postdoctoral training in genetics at Stanford University.
Aktive Positionen von Ansuman Satpathy
| Unternehmen | Position | Beginn |
|---|---|---|
Immunai, Inc.
 Immunai, Inc. Packaged SoftwareTechnology Services Immunai, Inc. engages in decoding of immune system to improve health. It offers an immune profiling platform, which is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines. The company was founded by Noam Solomon, Luis Voloch, Danny Wells, Ansuman Satpathy and Dan R. Littman in December 2018 and is headquartered in New York, NY. | Gründer | 01.12.2018 |
Wing Venture Management LLC
 Wing Venture Management LLC Investment ManagersFinance Wing Venture Management LLC (Wing Venture Partners) is a venture capital firm founded in 2013 by Gaurav Garg and Peter Wagner. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 01.11.2022 |
Ehemalige bekannte Positionen von Ansuman Satpathy
| Unternehmen | Position | Ende |
|---|---|---|
Cartography Biosciences, Inc.
 Cartography Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cartography Biosciences, Inc. is a biotech company that specializes in developing tumor-selective therapeutics using a unique genomics and computational platform. The company is based in Foster City, CA. The company integrates data from proprietary sample sourcing relationships, a comprehensive reference atlas, and target identification algorithms to identify the cells of interest and the single or pairs of targets that are most specific to the intended target cells. Cartography Biosciences is unlocking the full potential of immunotherapy by discovering and developing therapeutics as precise as their targets. The company was founded by Ansuman Satpathy, Howard Y. Chang, Kevin Parker. Kevin Parker has been the CEO since incorporation. | Gründer | - |
Ausbildung von Ansuman Satpathy
| University of Washington | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Wing Venture Management LLC
Wing Venture Management LLC Investment ManagersFinance Wing Venture Management LLC (Wing Venture Partners) is a venture capital firm founded in 2013 by Gaurav Garg and Peter Wagner. The firm is headquartered in Palo Alto, California. | Finance |
Immunai, Inc.
Immunai, Inc. Packaged SoftwareTechnology Services Immunai, Inc. engages in decoding of immune system to improve health. It offers an immune profiling platform, which is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines. The company was founded by Noam Solomon, Luis Voloch, Danny Wells, Ansuman Satpathy and Dan R. Littman in December 2018 and is headquartered in New York, NY. | Technology Services |
Cartography Biosciences, Inc.
Cartography Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cartography Biosciences, Inc. is a biotech company that specializes in developing tumor-selective therapeutics using a unique genomics and computational platform. The company is based in Foster City, CA. The company integrates data from proprietary sample sourcing relationships, a comprehensive reference atlas, and target identification algorithms to identify the cells of interest and the single or pairs of targets that are most specific to the intended target cells. Cartography Biosciences is unlocking the full potential of immunotherapy by discovering and developing therapeutics as precise as their targets. The company was founded by Ansuman Satpathy, Howard Y. Chang, Kevin Parker. Kevin Parker has been the CEO since incorporation. | Health Technology |
